Jeffrey S. Wefel, Ph.D., ABPP
Professor, Neuro-Oncology and Radiation Oncology
Dr. Wefel is a board-certified neuropsychologist, Neuropsychology Section Chief, and Professor with Tenure in the Department of Neuro-Oncology and Department of Radiation Oncology. He completed his clinical neuropsychology training at the University of Houston, internship at the University of Chicago Medical Center, and fellowship at the University of Texas M.D. Anderson Cancer Center. His research activities seek to characterize the prevalence, pattern, course, risks, and biologic and neural substrates for the development of neurocognitive dysfunction associated with cancer and cancer therapies. Ultimately, this will lead to identification and testing of interventions to prevent and/or minimize cognitive dysfunction. He is the neurocognitive study chair on numerous cooperative groups, industry-sponsored and investigator-initiated trials involving patients with breast cancer, melanoma, brain tumor, and brain metastasis, many of which integrate cognitive and neuroimaging outcomes as well as exploration of genetic moderators of cognitive and brain outcomes.
Catherine Sullaway, M.S.
Research Laboratory Manager
Katie completed her Master of Science in Clinical Research Management at Arizona State University. With over a decade of experience in the Wefel Lab, she manages our portfolio of protocols and clinical trials. She is responsible for managing training, certification and data quality assurance SOPs for multi-national clinical trials, patient testing for investigator-initiated trials, regulatory and data management, and is the liaison with the DoCM IT team for our comprehensive neuropsychology database.
Kyle R. Noll, Ph.D., ABPP
Dr. Noll is a board-certified neuropsychologist and associate professor in the Department of Neuro-Oncology. He completed his Ph.D. at the University of Texas Southwestern Medical Center at Dallas and postdoctoral fellowships at Baylor College of Medicine and The University of Texas M.D. Anderson Cancer Center. He joined the MD Anderson faculty in 2015. His research activities focus on understanding contributors to neurocognitive dysfunction in patients with brain tumors, including relationships between tumor, genetic, and sociodemographic characteristics.
Ashley Thomas, B.S.
Ashley completed her Bachelor of Science in Psychology and Child Learning and Development at the University of Texas at Dallas. Ashley tests patients for investigator-initiated clinical trials. She also assists with training, certification and data quality assurance for multi-national clinical trials.